Advertisement

Picture EBD Group BioPharm America 2018 Boston September 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Ireland and UK or involving organisations from these countries.

Total search results: 1809 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Remote Diagnostic Technologies–Philips: investment, 201806 acquisition €na of RDT by Philips 2018-06-13
Roche–Microbiotica: microbiomics, 201806– collab multi-year up to $534m r+d + commerc of markers + targets + treatments for IBD w Genentech 2018-06-06
Roivant–Oxford BioMedica: Parkinson’s gene therapy, 201806– license ww excl to OXB-102 $30m upfront + $812.5m milestones to Axovant Sciences 2018-06-06
Univ Birmingham–Thermo Fisher: mass spectrometer, 201806 supply existent early customer Orbitrap ID-X Tribrid MS system at PCB 2018-06-04
Arix Bioscience–Evotec: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutchinson Cancer Center 2018-05-31
Arix Bioscience–Fred Hutchinson: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutch with Evotec 2018-05-31
Evotec–Fred Hutchinson: drug discovery, 201805–202304 collab partnership LAB591 for early-stage projects out of Fred Hutch with Arix Bioscience 2018-05-31
Univ Tübingen–ERS Genomics: CRISPR technology, 201804– license €na to NMI + NMI TT Pharmaservices to expand custom cell-based research services 2018-05-31
F-Star–Denali Therapeutics: investment, 201805 acquisition of F-Star Gamma Ltd via early exercise of option for asset-centric vehicle 2018-05-30
ThromboGenics–Bicycle Therapeutics: small-molecule drugs, 201805– collab expansion r+d of bicycle peptides for eye diseases 2018-05-25
AstraZeneca–Bicycle Therapeutics: small-molecule drugs, 201805– collab expansion r+d of bicycle peptides for respiratory + cardio-metabolic diseases 2018-05-24
Bicycle Therapeutics–Argot Partners: public relations, 201805 service existent IR by Argot Partners 2018-05-24
Stable Arm (MY)–Microsaic: mass spectrometer, 201805– distribution of Microsaic’s 4500 MiD MS detector in Malaysia 2018-05-24
Orbit Discovery–Borealis Ventures: investment, 201805 financing round Series A totalling £6.9m incl new + co-investor Borealis Ventures 2018-05-23
Orbit Discovery–Perivoli Trust: investment, 201805 financing round Series A totalling £6.9m incl new + co-investor Perivoli Innovations 2018-05-23
Orbit Discovery–RT Ventures: investment, 201805 financing round Series A totalling £6.9m incl new + co-investor RT Ventures 2018-05-23
Orbit Discovery–SEVERAL: investment, 201805 financing round Series A £6.9m led by Oxford Sciences Innovation 2018-05-23
Orbit Discovery–Univ Oxford: investment, 201805 financing round Series A totalling £6.9m incl existing + lead investor Oxford Sciences Innovation 2018-05-23
Bionure–Alta Partners: investment, 201805 financing round Series A totalling €4m incl lead investor Alta Life Sciences 2018-05-16
Bionure–SEVERAL: investment, 201805 financing round Series A €4m led by Alta Life Sciences 2018-05-16
Otsuka–Thermo Fisher: electron microscope, 201805 supply of Glacios Cryo-TEM to Astex Pharmaceuticals Ltd 2018-05-16
Univ Cambridge–Thermo Fisher: electron microscope, 201805 supply existent Krios Cryo-TEM at Cambridge Univ 2018-05-16
Alfatest (IT)–Applied Photophysics: analytical instruments, 201805– distribution of Chirascan CD + SX stoppe-flow systems in Italy by Alfatest 2018-05-15
Applied Photophysics–Zyme Communications: public relations, 201805 service existent by Zyme 2018-05-15
Paralab (PT)–Applied Photophysics: analytical instruments, 201805– distribution of Chirascan CD + SX stoppe-flow systems in ES +PT by Paralab 2018-05-15
PhoreMost–SEVERAL: investment, 201805 financing round Series A £11m incl Jonathan Milner + Amadeus Capital + Cambridge Enterprise + Morningside 2018-05-15
Xenikos–SEVERAL: investment, 201805 financing round Series B $30m incl new investors Medicxi Ventures + RA Capital Management 2018-05-15
Memo Therapeutics–Redalpine: investment, 201805 financing round Series A2 totalling CHF5m incl existing investor Redalpine Venture Partners 2018-05-09
Memo Therapeutics–Schroders: investment, 201805 financing round Series A2 totalling CHF5m incl new investor Schroder Adveq 2018-05-09
Memo Therapeutics–SEVERAL: investment, 201805 financing round Series A2 CHF5m incl Schroder Adveq + investiere.ch + Redalpine Ventures et al. 2018-05-09
Memo Therapeutics–Verve Capital Partners: investment, 201805 financing round Series A2 totalling CHF5m incl new investor investiere.ch 2018-05-09
Memo Therapeutics–Zürcher Kantonalbank: investment, 201805 financing round Series A2 totalling CHF5m incl existing investor ZKB 2018-05-09
Rightek (TW)–Microsaic: mass spectrometer, 201805– distribution of Microsaic’s 4500 MiD MS detector in Taiwan 2018-05-09
Luye Pharma–AstraZeneca: quetiapine fumarate, 201805– acquisition of rights to Seroquel + Seroquel XR for $538m in GB + CN + et al. by Luye Pharma 2018-05-07
Evotec–ERS Genomics: CRISPR technology, 201804– license €na to expand Evotec’s CRISPR-based service offering from ERS Genomics Ltd 2018-05-02
Invizius–Mercia Technologies: investment, 201805 investment £500k by Mercia Fund Managers 2018-05-02
Crescendo Biologics–SEVERAL: investment, 201805 financing round Series B €57m led by Andera Partners 2018-04-30
LabCorp–Eurofins: investment, 201804– acquisition $670m cash/debt free of Covance Food Solutions from LabCorp by Eurofins 2018-04-30
Synthorx–SEVERAL: investment, 201804 financing round Series C $63m led by OrbiMed 2018-04-30
A-Mansia–BPCE: investment, 201804 financing round Series A first closing totalling €13m incl lead investor Seventure Partners 2018-04-27
A-Mansia–Instinctif Partners: public relations, 201804 service existent by Instinctif 2018-04-27
A-Mansia–SEVERAL: investment, 201804 financing round Series A first closing €13m led by Seventure Partners 2018-04-27
A-Mansia–Wallonia (govt): grant, 201804 non-dilutive grant €3m from Wallonia regional govt 2018-04-27
Jellagen–SEVERAL: investment, 201804 financing round £3.8m led by Newable Private Investing + Development Bank Wales + angel investors 2018-04-27
Polyphor–Consilium: public relations, 201804 service existent international media relations by CSC 2018-04-27
BenevolentAI–SEVERAL: investment, 201804 financing round $115m from new + exsiting investors incl Woodford 2018-04-19
Inflection Biosciences–Trinity College Dublin: cancer immunotherapy, 201804– collab research with TBSI for PIM/PI3K inhibitors 2018-04-16
Shire–Servier: investment, 201804– acquisition of Shire’s oncology business for $2.4b in cash by Servier ANNOUNCED 2018-04-16
Enterprise Therapeutics–Epidarex Capital: investment, 201804 financing round Series B totalling £29m ($41m) incl existing co-investor Epidarex Capital 2018-04-12
Enterprise Therapeutics–Forbion: investment, 201804 financing round Series B totalling £29m ($41m) incl new + co-investor Forbion 2018-04-12
Enterprise Therapeutics–IP Group: investment, 201804 financing round Series B totalling £29m ($41m) incl existing co-investor IP Group 2018-04-12
Enterprise Therapeutics–Novartis: investment, 201804 financing round Series B totalling £29m ($41m) incl co-lead investor Novartis Venture Fund 2018-04-12
Enterprise Therapeutics–SEVERAL: investment, 201804 financing round Series B £29m ($41m) co-led by Versant Ventures + NVF 2018-04-12
Enterprise Therapeutics–Versant Ventures: investment, 201804 financing round Series B totalling £29m ($41m) incl co-lead investor Versant Ventures 2018-04-12
Enterprise Therapeutics–Zyme Communications: public relations, 201804 service existent by Zyme 2018-04-12
Knauer–Microsaic: mass spectrometry, 201804– collab integration of Microsaic’s compact MS techn in Knauer’s LC platform 2018-04-12
Orchard Therapeutics–GSK: gene therapy, 201804 transfer of GSK’s gene therapy portfolio to Orchard with 19.9% shareholding for GSK 2018-04-12
Orchard Therapeutics–GSK: investment, 201804 shareholding of 19.9% for GSK in return for transfer of gene therapy portfolio to Orchard 2018-04-12
Igem Therapeutics–Iontas: antibody cancer drug, 201804– collab identification IgE antibodies against two cancer targets 2018-04-04
Iontas–Zyme Communications: public relations, 201804 service existent by Zyme 2018-04-04
Brainomix–Boehringer: investment, 201804 financing round totalling £7m incl new + co-investor BIVF 2018-04-03
Brainomix–SEVERAL: investment, 201804 financing round £7m led by Parkwalk Advisors + incl BIVF + Chimera Partners + Oxford Univ 2018-04-03
AstraZeneca–Compugen: antibody cancer drug, 201804– license $10m upfront + $200m milestones + royalties developm bi-/multi-specific ABs to MedImmune 2018-04-02
Eagle Genomics–SEVERAL: investment, 201804–201806 financing round ongoing with $1m raised until 1st May 2018-04-01
Unimicro Technologies–Microsaic: mass spectrometer, 201803– collab integration of 4500 MiD MS detector w Unimicro CEO products for sale in China 2018-03-28
Novartis–GSK: investment, 201803– acquisition $13b of 36.5% stake of Novartis in OTC joint venture giving GSK 100% ownership 2018-03-27
United Kingdom (govt)–Microsaic: mass spectrometry, 201803– collab evaluating Microsaic MS for online QC in biopharma production at CPI Darlington 2018-03-23
Deinove–Redx Pharma: antibiotics, 201803– option + license agreem for Redx’ Novel Bacterial Topoisomerase Inhibitor programme 2018-03-22
Oxford Nanopore–China Construction Bank: investment, 201803 private placement totalling £100m ($140m) incl new investor CCBI 2018-03-20
Oxford Nanopore–Hostplus: investment, 201803 private placement totalling £100m ($140m) incl new investor Hostplus 2018-03-20
Oxford Nanopore–SEVERAL: investment, 201803 private placement £100m ($140m) incl GIC + CCBI + Hostplus + existing investors 2018-03-20
Oxford Nanopore–Singapore (govt): investment, 201803 private placement totalling £100m ($140m) incl new investor GIC 2018-03-20
Biocatalysts Ltd–BRAIN: investment, 201803 acquisition of majority stake in Biocatalysts Ltd by BRAIN AG 2018-03-17
Kiadis–Optimum Strategic Communications: public relations, 201803 service existent by Optimum 2018-03-14
Orchard Therapeutics–Cowen: investor conference, 201803 supply service Orchard presents at Cowen & Co Annual Health Care Conference 2018 2018-03-14
OxSyBio–SEVERAL: investment, 201803 financing round Series A £10m led by Woodford + incl IP Group + Parkwalk Advisors 2018-03-12
Oxford Vacmedix–SEVERAL: investment, 201803 financing round Series A $12.5m from Cancer ROP (KR) + existing Chinese investors 2018-03-06
Autolus–SEVERAL: investment, 201803– planned US IPO of ADSs $117.2–$132.8m at Nasdaq Global Market 2018-03-05
Owlstone–Aviva: investment, 201803 financing round totalling £11m incl existent + co-lead investor Aviva Ventures 2018-03-05
Owlstone–Horizons Ventures: investment, 201803 financing round totalling £11m incl new + co-lead investor Horizons Ventures 2018-03-05
Owlstone–Huntsworth: public relations, 201803 service existent IR by Citigate Dewe Rogerson 2018-03-05
Owlstone–SEVERAL: investment, 201803 financing round £11m ($15m) co-led by Horizons Ventures + Aviva Ventures 2018-03-05
BioPharmaSpec–Danaher: mass spectrometer, 201803 supply existent Sciex 5800 MALDI TOF/TOF mass spetrometers 2018-03-03
BioPharmaSpec–Waters: mass spectrometer, 201803 supply existent Xevo G2 Q-TOF MS systems with ES + Nanospray 2018-03-03
BioPharmaSpec–Waters: mass spectrometer, 201803 supply existent Xevo G2-XS Q-TOF MS systems with ES + Nanospray 2018-03-03
BioPharmaSpec–Waters: mass spectrometer, 201803 supply existent Xevo TQ-S systems with ESAB 2018-03-03
Acacia Pharma–Huntsworth: public relations, 201803 service existent by Citigate Dewe Rogerson 2018-03-02
Agilent–Imperial College: analytical technology, 201802– collab with new Agilent sponsored Measurement Site at ICL incl demo + showcasing solutions 2018-02-28
Arix Bioscience–SEVERAL: investment, 201802–201803 capital increase £87m with 38.6m new ordinary shares to new + existing investors 2018-02-28
Imperial College–Agilent: analytical instruments, 201802– supply of instruments for new Agilent sponsored Measurement Site at ICL 2018-02-28
Viela Bio–SEVERAL: investment, 201802 up to $250m funding from investor consortium at spin-out with AZ remaining largest minority shareholder 2018-02-28
LifeArc–Zyme Communications: public relations, 201802 service existent by Zyme 2018-02-27
City Analysts–Eurofins: investment, 201802 acquisition of City Analysts Ltd by Eurofins 2018-02-23
Orchard Therapeutics–RBC Capital Markets: investor conference, 201802 supply service Orchard at RBC Capital Markets Global Healthcare Conference 2018-02-21
Congenica–Science Foundation Ireland: bioinformatics, 201802– collab developm diagnosis of genetic epilepsy using Sapientia s/w with FutureNeuro 2018-02-12
Lonza–Kirkstall: cell culture system, 201802– collab ww marketing + distribution of Quasi Vivo System by Lonza 2018-02-12
Nosopharm–Andrew Lloyd Associates: public relations, 201802 service existent by ALA 2018-02-12
Impact Biomedicines–Medicxi Ventures: investment, 201801 existing investor 2018-02-07
LCF Rothschild–SEVERAL: investment, 201802 closing €345m of BioDiscovery 5 fund of EdRIP 2018-02-07
Acacia Pharma–SEVERAL: investment, 201802–201803 initial global offering €40m private placement 11.1m shares at €3.6 + listing on Euronext Brussels 2018-02-05
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19  next pagenext page



Advertisement

Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

» top